Testbed
Basic formatting
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
italic text
bold text
strike-through text
Text with extra blank lines above and below
- list item a
- list item b
- list item c
- ordered list item 1
- ordered list item 2
- ordered list item 3
- top level list item
- nested list item
- even deeper nested list item
- nested list item
Plain image:
Heading 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Heading 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Heading 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Heading 4
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Heading 5
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
| TABLE | Game 1 | Game 2 | Game 3 | Total |
|---|---|---|---|---|
| Anna | 144 | 123 | 218 | 485 |
| Bill | 90 | 175 | 120 | 385 |
| Cara | 102 | 214 | 233 | 549 |
It was the best of times it was the worst of times. It was the age of wisdom, it was the age of foolishness. It was the spring of hope, it was the winter of despair.
// some code with syntax highlighting
const popup = document.querySelector("#popup");
popup.style.width = "100%";
popup.innerText =
"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.";
This sentence has inline code, useful for making references to variables, packages, versions, etc. within a sentence.
Lorem ipsum dolor sit amet.
Consectetur adipiscing elit.
Sed do eiusmod tempor incididunt.
Hidden content
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Jekyll Spaceship
| Stage | Direct Products | ATP Yields |
|---|---|---|
| Glycolysis
|
2 ATP | |
| 2 NADH | 3–5 ATP | |
| Pyruvaye oxidation | 2 NADH | 5 ATP |
| Citric acid cycle
|
2 ATP | |
| 6 NADH | 15 ATP | |
| 2 FADH | 3 ATP | |
| 30–32 ATP |
$ a * b = c ^ b $
$ 2^{\frac{n-1}{3}} $
$ \int_a^b f(x)\,dx. $
Components
Section
Section, background
Section, dark=true
Section, background dark=true
Section, size=wide
Section, size=full w/ figure
Figure
px width
% width
px height
px width, svg
% width, svg
px height, svg
Button
Icon
Lorem Ipsum Dolor
Feature
Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
List
List citations
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
List projects
A dockerized workflow integrating ClinVar and InterVar germline sequence variant classification
A harmonized open-source multi-omic dataset from > 6,000 pediatric cancer patients with > 7,000 tumor events across more than 100 histologies.
A global open science initiative characterizing over 1,000 pediatric brain tumors.
Distinct associations of genetic ancestry-based superpopulations exist within pediatric CNS tumor histologic and molecular subtypes and correlate with survival outcomes and treatment.
Characterization of aberrant splicing in pediatric central nervous system tumors reveals CLK1 as a candidate oncogenic dependency
List team members
List blog posts
2025
We were thrilled to contribute to the recent publication, “Germline analysis of an international cohort of pediatric diffuse midline glioma patients”, led by collaborator Dr. Marion Mateos. In this project, we assessed pathogenicity of germline variants driving DIPG and DMG. Read more about it here.
We are happy to announce our recruitment of Dr. Bicna Song as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.
Dr. Rokita recently sat down with the press team at Children’s National to discuss her laboratory’s research, the development of the Brain Tumor Institute (BTI) Bioinformatics Core, and her collaborative and open science vision for the future. Read all about it here!
We are happy to announce the publication of “Germline pathogenic DROSHA variants are linked to pineoblastoma and Wilms tumor predisposition”, an international collaboration in which we describe a new tumor syndrome characterized by pathogenic germline DROSHA variants. Read more about it here.
We are thrilled to welcome Alex Sickler as a Bioinformatics Engineer in the Rokita Lab and Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Alex joins us after many productive years of bioinformatics engineering and infrastructure management work at GeneDx, the National Cancer Institute, and the Children’s Hospital of Philadelphia (CHOP).
We were thrilled to be a part of the recent publication, “Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular Characteristics”, led by our collaborator Dr. Anahita Fathi Kazerooni. Read more about it here.
Our latest manuscript, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors”, work led by Dr. Ryan Corbett, is now preprinted on MedRxiv!
From Dr. Yael Mosse’s laboratory, we are happy to see the work of Dr. Smita Matkar, “Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma”, published today. We were happy to have played a small role in this work! Read more about it here.
As a part of our splice-derived neoepitope identification research, we partnered with Dr. Andrei Thomas-Tikhonenko’s laboratory at Children’s Hospital of Philadelphia in which they validated an NRCAM splice event as a targetable immunotherapeutic target for pediatric high-grade gliomas. Please read more in “Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma” here.
We are thrilled to welcome Dr. Ryan Corbett as a Senior Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Ryan joins us after two years of outstanding work under the mentorship of Dr. Rokita at the Children’s Hospital of Philadelphia (CHOP).
2024
Our newest manuscript, “Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC”, work led by Dr. Ryan Corbett, has been accepted in NeuroOncology!
We are thrilled to announce the opening of the Rokita Lab at Children’s National within the Brain Tumor Institute (BTI) and Center for Cancer and Immunology Research (CCIR)! Situated in a leading pediatric institution, our lab is equipped with cutting-edge technology and resources, fostering a collaborative environment for groundbreaking discoveries. We’re excited to accelerate our research and expand our efforts to improve outcomes for children with brain cancer.
Citation
Card
Portrait
Post Excerpt
Alert
Tip Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Help Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Info Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Success Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Warning Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Error Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Tags
Float
Figures
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Code
const test = "Lorem ipsum dolor sit amet, consectetur adipiscing elit.";
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a. Tristique magna sit amet purus gravida quis blandit turpis cursus. Ultrices eros in cursus turpis massa tincidunt dui ut ornare. A cras semper auctor neque vitae tempus quam pellentesque nec. At tellus at urna condimentum mattis pellentesque. Ipsum consequat nisl vel pretium. Ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida. Integer vitae justo eget magna fermentum iaculis eu non diam. Mus mauris vitae ultricies leo integer malesuada nunc vel. Leo integer malesuada nunc vel risus. Ornare arcu odio ut sem nulla pharetra. Purus semper eget duis at tellus at urna condimentum. Enim neque volutpat ac tincidunt vitae semper quis lectus.
Grid
Regular
With Markdown images
Square
With figure components
Grid of citations
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Grid of blog posts
2025
We were thrilled to contribute to the recent publication, “Germline analysis of an international cohort of pediatric diffuse midline glioma patients”, led by collaborator Dr. Marion Mateos. In this project, we assessed pathogenicity of germline variants driving DIPG and DMG. Read more about it here.
We are happy to announce our recruitment of Dr. Bicna Song as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.
Dr. Rokita recently sat down with the press team at Children’s National to discuss her laboratory’s research, the development of the Brain Tumor Institute (BTI) Bioinformatics Core, and her collaborative and open science vision for the future. Read all about it here!
We are happy to announce the publication of “Germline pathogenic DROSHA variants are linked to pineoblastoma and Wilms tumor predisposition”, an international collaboration in which we describe a new tumor syndrome characterized by pathogenic germline DROSHA variants. Read more about it here.
We are thrilled to welcome Alex Sickler as a Bioinformatics Engineer in the Rokita Lab and Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Alex joins us after many productive years of bioinformatics engineering and infrastructure management work at GeneDx, the National Cancer Institute, and the Children’s Hospital of Philadelphia (CHOP).
We were thrilled to be a part of the recent publication, “Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular Characteristics”, led by our collaborator Dr. Anahita Fathi Kazerooni. Read more about it here.
Our latest manuscript, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors”, work led by Dr. Ryan Corbett, is now preprinted on MedRxiv!
From Dr. Yael Mosse’s laboratory, we are happy to see the work of Dr. Smita Matkar, “Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma”, published today. We were happy to have played a small role in this work! Read more about it here.
As a part of our splice-derived neoepitope identification research, we partnered with Dr. Andrei Thomas-Tikhonenko’s laboratory at Children’s Hospital of Philadelphia in which they validated an NRCAM splice event as a targetable immunotherapeutic target for pediatric high-grade gliomas. Please read more in “Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma” here.
We are thrilled to welcome Dr. Ryan Corbett as a Senior Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Ryan joins us after two years of outstanding work under the mentorship of Dr. Rokita at the Children’s Hospital of Philadelphia (CHOP).
2024
Our newest manuscript, “Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC”, work led by Dr. Ryan Corbett, has been accepted in NeuroOncology!
We are thrilled to announce the opening of the Rokita Lab at Children’s National within the Brain Tumor Institute (BTI) and Center for Cancer and Immunology Research (CCIR)! Situated in a leading pediatric institution, our lab is equipped with cutting-edge technology and resources, fostering a collaborative environment for groundbreaking discoveries. We’re excited to accelerate our research and expand our efforts to improve outcomes for children with brain cancer.
Cols
Text
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a. Tristique magna sit amet purus gravida quis blandit turpis cursus. Ultrices eros in cursus turpis massa tincidunt dui ut ornare. A cras semper auctor neque vitae tempus quam pellentesque nec. At tellus at urna condimentum mattis pellentesque. Ipsum consequat nisl vel pretium. Ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida. Integer vitae justo eget magna fermentum iaculis eu non diam. Mus mauris vitae ultricies leo integer malesuada nunc vel. Leo integer malesuada nunc vel risus. Ornare arcu odio ut sem nulla pharetra. Purus semper eget duis at tellus at urna condimentum. Enim neque volutpat ac tincidunt vitae semper quis lectus.
Images
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Code
const test = "Lorem ipsum dolor sit amet";
const test = "Lorem ipsum dolor sit amet";
const test = "Lorem ipsum dolor sit amet";